Halaman 3 - Kanker hati stadium 3 Dokter Terbaik - TOP-87 dokter

Dr. Greenberg memimpin Departemen Bedah Kolorektal dan merupakan spesialis terkemuka dalam bedah abdomen besar, termasuk prosedur Whipple yang kompleks.

• Lebih dari 20 tahun pengalaman bedah
• Melakukan teknik bedah terbuka maupun invasif minimal
• Ahli dalam reseksi tumor hati dan pankreas
• Berpraktik di Sourasky Medical Center (Ichilov) yang mutakhir

Associate Professor Tahsin Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal di Rumah Sakit Universitas Istinye Liv.

• Lebih dari 10 tahun pengalaman di bidang onkologi
• Berspesialisasi dalam kasus kanker yang kompleks
• Bekerja di Klinik Onkologi Ankara dan rumah sakit terkemuka lainnya
• Dipromosikan menjadi Associate Professor pada tahun 2016

Associate Professor Dr. Yusuf Acikgoz membawa keahlian dari Ohio State University – kini memimpin kasus onkologi di Rumah Sakit Universitas Lokman Hekim Ankara.

• Spesialisasi dalam Onkologi Medis dengan pelatihan terfokus selama 7+ tahun
• Berpartisipasi dalam uji klinis Fase III internasional untuk pengobatan kanker stadium lanjut
• Fasih berbahasa Inggris dengan berbagai sertifikasi internasional
• Anggota American Society of Clinical Oncology

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Spesialis dalam bedah laparoskopi lanjutan dan onkologi di rumah sakit bergengsi Universitas Istanbul. Melakukan teknik invasif minimal untuk kasus kanker hati yang kompleks.

• Bersertifikat dewan medis dengan pengalaman bedah lebih dari 30 tahun
• Menerima pelatihan khusus dalam bedah antirefluks laparoskopi dan bedah bariatrik
• Fellowship lanjutan dalam teknik bedah kanker onkologi
• Melakukan operasi di Rumah Sakit Büyük Anadolu

Dr. Auala Hubert mengepalai Pusat Kanker Gastrointestinal di Hadassah Medical Center, dengan 33 tahun pengalaman di bidang onkologi dan radioterapi.

• Spesialisasi dalam onkologi medis dan radioterapi untuk kanker hati
• Dokter senior di Departemen Onkologi Rumah Sakit Universitas Hadassah
• Menjalani pelatihan di Hebrew University dan Rumah Sakit Universitas Hadassah
• Anggota Masyarakat Onkologi Klinis Israel dan Asosiasi Kanker

Professor Madya Babek Tabandeh berspesialisasi dalam bedah kanker hati dan teknik invasif minimal di Rumah Sakit Medical Park Goztepe.

• Lebih dari 30 tahun pengalaman dalam bedah umum
• Penulis lebih dari 40 dokumen medis
• Anggota American College of Surgeons dan Liver Transplantation Society
• Mengajar di Fakultas Kedokteran Universitas Bahçeşehir

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Associate Professor Nail Paksoy berspesialisasi dalam kanker hati di Rumah Sakit Medipol Bahçelievler, dengan riset mendalam di bidang onkologi.

• Sertifikasi Dewan ESMO dalam Onkologi Medis
• Berpartisipasi aktif dalam uji klinis internasional untuk pengobatan kanker
• Menerbitkan berbagai makalah penelitian tentang berbagai jenis kanker
• Pelatihan fellowship di Institut Onkologi Universitas Istanbul

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Spesialis dalam pengobatan kanker hati dengan pengalaman luas di bidang onkologi medis. Dr. Ozden berfokus pada perawatan personal bagi pasien kanker hati stadium 3 di Rumah Sakit VM Medical Park Pendik.

• 6 tahun pelatihan subspesialis onkologi medis di Fakultas Kedokteran Universitas Kocaeli
• 16+ tahun pengalaman dalam penyakit dalam dan onkologi
• Menempuh pendidikan di Fakultas Kedokteran Cerrahpaşa Universitas Istanbul – salah satu sekolah kedokteran ternama di Turki

Spesialis dalam viroterapi – sebuah pendekatan imunoterapi mutakhir untuk kanker hati – Dr. Jaunalksne membawa 30+ tahun keahlian di bidang imunologi.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Berfokus pada imunoterapi inovatif untuk pengobatan kanker

Dr. Alemdar berspesialisasi dalam pengobatan kanker hati dengan latar belakang akademis yang kuat dan pengalaman rumah sakit yang luas.

• Pengalaman lebih dari 15 tahun di bidang penyakit dalam dan onkologi
• Pelatihan onkologi medis di Fakultas Kedokteran Universitas Akdeniz
• Pernah bekerja di berbagai rumah sakit terkemuka di Turki
• Anggota Asosiasi Onkologi Medis Turki

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).